DECODE Protocol

A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi‐Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure‐Response Relationship of different doses of Delpazolid in combination with Bedaquiline Delamanid Moxifloxacin in Adult Subjects with Newly Diagnosed, Uncomplicated, Smear‐Positive, Drug‐sensitive Pulmonary Tuberculosis

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29529788.v1
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DECODE Protocol

Figshare
Tuberculosis Research and Epidemiology
article

DECODE Protocol

article en

Abstract

A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi‐Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure‐Response Relationship of different doses of Delpazolid in combination with Bedaquiline Delamanid Moxifloxacin in Adult Subjects with Newly Diagnosed, Uncomplicated, Smear‐Positive, Drug‐sensitive Pulmonary Tuberculosis

Figshare
Good health and well-being
Openalex Percentile: Top 46%
Tuberculosis Research and Epidemiology
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

DECODE Protocol · Figshare (2025) | TGRS Research Map | TGRS